Meeting to be held on August 26-28 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLO:
- Allogene Therapeutics Faces Financial Uncertainty Amid New U.S. Tariffs and Regulatory Challenges
- Promising Pipeline and Strategic Advancements Drive Buy Rating for Allogene Therapeutics
- Allogene Therapeutics Advances in CAR T Cell Therapy
- Allogene Therapeutics reports Q2 EPS (23c), consensus (27c)
- Allogene Therapeutics options imply 16.7% move in share price post-earnings